There is a new shot out, not sure if it's in Canada or the United States. But awhile back there was a twice yearly shot coming out, but I don't remember which country.

Cabenuva is a two injection every two months.

Internet Source:
(ALWAYS TALK TO YOUR PROVIDER(S) FIRST)

Yes, besides Cabenuva (cabotegravir/rilpivirine), other injectable HIV medicines available or in development include Lenacapavir (Sunlenca/Yeztugo) for treatment/prevention (dosed every 6 months) and Ibalizumab (Trogarzo), plus ongoing trials for combinations like Sunlenca + bNAbs, showing a shift to less frequent, more convenient long-acting options.
Currently Approved Injectable Medications (Beyond Cabenuva):
Lenacapavir (Sunlenca/Yeztugo): A new class (capsid inhibitor) that can be given as a twice-yearly injection for treatment (with other drugs) or prevention (Yeztugo), offering significant convenience.
Ibalizumab (Trogarzo): An antibody treatment (ibalizumab) used for heavily treatment-resistant HIV, administered less frequently than daily pills.
In Development & Future Possibilities:
Lenacapavir Combinations: Trials are exploring combining Lenacapavir with other long-acting agents for even longer intervals (e.g., every 6 months).
Broadly Neutralizing Antibodies (bNAbs): Combinations with Sunlenca are being tested for potential twice-yearly injections.
Novel Drug Candidates: New drugs like VH-184 and VH-499 are showing promise in trials, potentially leading to future long-acting injectables.
Key Trend: The field is moving towards fewer injections (monthly, every few months, or even twice yearly) with drugs like Lenacapavir, offering a major shift from daily oral regimens.